Abstract
Infectious diseases have been evolving and re-evolving over the ages and causing immense misery to humans. Among them, some have been prevented and eradicated, but few are still threatening the modern era since their origin. The majority of these infectious diseases are poverty-driven, hence highly prevalent in the lower-income and mid-income countries of Africa and Asia. The world’s deadliest infections, including Tuberculosis, Malaria and HIV/AIDS, have been considered as the “Big Three” infectious diseases (BTIDs). With leading infections and deaths every year, the BTIDs have been recognized as the world’s greatest pandemics. In light of these alarming situations, this review has been aimed to provide a comprehensive overview of the current status of chemotherapeutics, associated challenges and future perspectives of BTIDs.
Keywords: “Big Three” infectious diseases, Tuberculosis, Malaria, HIV/AIDS, Chemotherapeutic agents, BTIDs, burden.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:“Big Three” Infectious Diseases: Tuberculosis, Malaria and HIV/AIDS
Volume: 21 Issue: 31
Author(s): Parameshwar Makam*Ramkishore Matsa
Affiliation:
- Chemical Science Research Group, Advanced Research Group, Division of Research and Development, Lovely Professional University, Phagwara, Punjab-144411,India
Keywords: “Big Three” infectious diseases, Tuberculosis, Malaria, HIV/AIDS, Chemotherapeutic agents, BTIDs, burden.
Abstract: Infectious diseases have been evolving and re-evolving over the ages and causing immense misery to humans. Among them, some have been prevented and eradicated, but few are still threatening the modern era since their origin. The majority of these infectious diseases are poverty-driven, hence highly prevalent in the lower-income and mid-income countries of Africa and Asia. The world’s deadliest infections, including Tuberculosis, Malaria and HIV/AIDS, have been considered as the “Big Three” infectious diseases (BTIDs). With leading infections and deaths every year, the BTIDs have been recognized as the world’s greatest pandemics. In light of these alarming situations, this review has been aimed to provide a comprehensive overview of the current status of chemotherapeutics, associated challenges and future perspectives of BTIDs.
Export Options
About this article
Cite this article as:
Makam Parameshwar *, Matsa Ramkishore, “Big Three” Infectious Diseases: Tuberculosis, Malaria and HIV/AIDS, Current Topics in Medicinal Chemistry 2021; 21 (31) . https://dx.doi.org/10.2174/1568026621666210916170417
DOI https://dx.doi.org/10.2174/1568026621666210916170417 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy
Current Drug Metabolism CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors
Current Medicinal Chemistry Herbal Folklore Medication for Liver Disorders
Current Traditional Medicine Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Primary Isolated Mediastinal Abscess Masquerading as Mediastinal Mass- A Needle did the Trick
Current Respiratory Medicine Reviews Synthetic Aspects and First-time Assessment of 2-amino-1,3-selenazoles Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders – A Focus on the Modulation of Host Tissue Function
Mini-Reviews in Medicinal Chemistry Control of Mycobacterium tuberculosis Infection by Glutathione
Recent Patents on Anti-Infective Drug Discovery Role of Ultraviolet (UV) Disinfection in Infection Control and Environmental Cleaning.
Infectious Disorders - Drug Targets Clinical Applications of Autoimmunity to Citrullinated Proteins in Rheumatoid Arthritis, from Improving Diagnostics to Future Therapies
Recent Patents on Inflammation & Allergy Drug Discovery 3D-QSAR Study on Ring Substituted Imidazoles for Their Antitubercular Activity
Letters in Drug Design & Discovery Advances in Zebrafish High Content and High Throughput Technologies
Combinatorial Chemistry & High Throughput Screening Aging and Oral Health: Effects in Hard and Soft Tissues
Current Pharmaceutical Design Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Design of multifunctional nanocarriers for delivery of anti-cancer therapy
Current Pharmaceutical Design Enoyl Reductases as Targets for the Development of Anti-Tubercular and Anti-Malarial Agents
Current Drug Targets The Role of Machine Learning in Centralized Authorization Process of Nanomedicines in European Union
Current Topics in Medicinal Chemistry Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application
Current Topics in Medicinal Chemistry Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets